C. Rea

发表

Fibrinogen as a Hemostatic Agent

B. Sørensen, J. Foley, O. H. Larsen, 2012, Seminars in Thrombosis & Hemostasis.

Enhancing the pharmacokinetic properties of recombinant factor VIII: first‐in‐human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A

D. Viuff, T. Matsushita, K. Kavaklı, 2013, Journal of thrombosis and haemostasis : JTH.

Real life experiences of a PK dosing study—Challenges and lessons learned.

E. Nielsen, S. Jönsson, P. Collins, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

FXIII: mechanisms of action in the treatment of hemophilia A

B. Sørensen, J. Foley, C. Rea, 2014, Journal of thrombosis and haemostasis : JTH.

An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A

D. Bevan, B. Sørensen, J. Foley, 2014, Annals of Hematology.

Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A

J. Ingerslev, B. Sørensen, J. Foley, 2011, Journal of thrombosis and haemostasis : JTH.

Three-month follow-up of pulmonary embolism in patients with COVID-19

M. Waller, C. Jolley, M. Whyte, 2021, Thrombosis Research.

Postdischarge venous thromboembolism following hospital admission with COVID-19

M. Whyte, C. Rea, B. Vadher, 2020, Blood.

Rivaroxaban for the treatment of superficial vein thrombosis, experience at King’s College Hospital

C. Rea, B. Vadher, R. Arya, 2021, British journal of haematology.

Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients

T. Barbui, R. Mesa, C. Harrison, 2012, Haematologica.

Reducing vascular risk – venous thromboembolism and anticoagulation

B. Hunt, C. Rea, 2009 .

Novel management of anticoagulant resistant thrombotic hypodysfibrinogenaemia.

C. Rea, B. Hunt, 2012, Thrombosis research.

Fibrinogen concentrate and cryoprecipitate but not fresh frozen plasma correct low fibrinogen concentrations following in vitro haemodilution.

B. Sørensen, C. Rea, C. Fenger-Eriksen, 2013, Thrombosis research.

The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding.

B. Sørensen, O. H. Larsen, C. Rea, 2011, Thrombosis research.

Temporal changes in clot lysis and clot stability following tranexamic acid in cardiac surgery

V. Hjortdal, J. Ingerslev, B. Sørensen, 2017, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors

T. Ueland, G. Tjønnfjord, P. Holme, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Pharmacokinetics, coagulation factor consumption and clinical efficacy in patients being switched from full‐length FVIII treatment to B‐domain‐deleted r‐FVIII and back to full‐length FVIII

S. Rangarajan, C. Rea, B. Sørensen, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

D. Lillicrap, B. Sørensen, J. Foley, 2012, Blood.

Factor XIII in the treatment of hemophilia A.

B. Sørensen, J. Foley, C. Rea, 2012, The New England journal of medicine.

Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic

C. Rea, B. Vadher, R. Arya, 2020, Thrombosis Research.

Three-month follow-up of pulmonary embolism in patients with COVID-19

M. Waller, C. Jolley, M. Whyte, 2021, Thrombosis Research.

Fibrinogen concentrate and cryoprecipitate but not fresh frozen plasma correct low fibrinogen concentrations following in vitro haemodilution.

B. Sørensen, C. Rea, C. Fenger-Eriksen, 2013, Thrombosis research.